Natarajan Sethuraman, Chief Scientific Officer: Entrada Therapeutics TRDA Sell · Filed 24/05/20

Trade details

Type: Insider sale
Amount: $146,963.25
Shares · price: 9,675 sh · $15.19 a share
Held after: 190,052 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanChief Scientific Officer
Trade date: 24/05/20
Filed: 24/05/20
Days to filing: 0 days

Sold 4.8% of holdings

Share of holding sold: 4.8%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/20~24/06/19

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29

Natarajan Sethuraman, Chief Officer — sold $147K of Entrada Therapeutics TRDA · 4.8% of holdings · 10b5-1 plan | Whalegun